Détail du document
Identifiant

oai:arXiv.org:2408.01883

Sujet
Computer Science - Computational E...
Auteur
Maleki, Morteza Ghahari, SeyedAli
Catégorie

Computer Science

Année

2024

Date de référencement

07/08/2024

Mots clés
pharmaceutical analysis major events health market
Métrique

Résumé

This study investigates the impact of significant health events on pharmaceutical stock performance, employing a comprehensive analysis incorporating macroeconomic and market indicators.

Using Ordinary Least Squares (OLS) regression, we evaluate the effects of thirteen major health events since 2000, including the Anthrax attacks, SARS outbreak, H1N1 pandemic, and COVID-19 pandemic, on the pharmaceutical sector.

The analysis covers different phases of each event beginning, peak, and ending to capture their temporal influence on stock prices.

Our findings reveal distinct patterns in stock performance, driven by market reactions to the initial news, peak impact, and eventual resolution of these crises.

We also examine scenarios with and without key macroeconomic (MA) and market (MI) indicators to isolate their contributions.

This detailed examination provides valuable insights for investors, policymakers, and stakeholders in understanding the interplay between major health events and health market dynamics, guiding better decision-making during future health related disruptions.

;Comment: 17 pages, 5 figures, under review

Maleki, Morteza,Ghahari, SeyedAli, 2024, Impact of Major Health Events on Pharmaceutical Stocks: A Comprehensive Analysis Using Macroeconomic and Market Indicators

Document

Ouvrir

Partager

Source

Articles recommandés par ES/IODE IA

MELAS: Phenotype Classification into Classic-versus-Atypical Presentations
presentations mitochondrial strokelike patients variability phenotype clinical melas
Protocol for the promoting resilience in stress management (PRISM) intervention: a multi-site randomized controlled trial for adolescents and young adults with advanced cancer
cancer quality of life anxiety depression hope coping skills communication intervention randomized ayas outcomes resilience care trial cancer prism-ac advanced